-
Loading metrics
Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis
-
Dhiraj Kumar Singh,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliations Special Centre for Molecular Medicine (SCMM), Jawaharlal Nehru University, New Delhi, India, International Centre for Genetic Engineering and Biotechnology, New Delhi, India, Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, Texas, United States of America
⨯ - Sultan Tousif,
- Ashima Bhaskar,
-
Annu Devi,
Roles Data curation, Investigation, Methodology
Affiliation Special Centre for Molecular Medicine (SCMM), Jawaharlal Nehru University, New Delhi, India
⨯ - Kriti Negi,
-
Barnani Moitra,
Roles Data curation, Formal analysis, Methodology
Affiliation Special Centre for Molecular Medicine (SCMM), Jawaharlal Nehru University, New Delhi, India
⨯ - Anand Ranganathan,
- Ved Prakash Dwivedi,
-
Gobardhan Das
Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: dasgo@mail.jnu.ac.in
Affiliation Special Centre for Molecular Medicine (SCMM), Jawaharlal Nehru University, New Delhi, India
⨯
https://orcid.org/0000-0001-5507-1197
Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis
- Dhiraj Kumar Singh,
- Sultan Tousif,
- Ashima Bhaskar,
- Annu Devi,
- Kriti Negi,
- Barnani Moitra,
- Anand Ranganathan,
- Ved Prakash Dwivedi,
- Gobardhan Das
-
- Published: August 20, 2021
- https://doi.org/10.1371/journal.ppat.1009805